Fluoxetine Versus Placebo in Advanced Cancer Outpatients
- 1 January 2004
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (1) , 204-205
- https://doi.org/10.1200/jco.2004.99.206
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Fluoxetine Versus Placebo in Advanced Cancer Outpatients: A Double-Blinded Trial of the Hoosier Oncology GroupJournal of Clinical Oncology, 2003
- Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptylineBreast Cancer Research and Treatment, 2001
- Paroxetine for the Prevention of Depression Induced by High-Dose Interferon AlfaNew England Journal of Medicine, 2001
- A controlled trial of fluoxetine and desipramine in depressed women with advanced cancerPsycho‐Oncology, 1998
- Pharmacological Treatment of Depression in Cancer PatientsThe British Journal of Psychiatry, 1996
- The effect of fluoxetine on anxiety and depression symptoms in cancer patientsActa Psychiatrica Scandinavica, 1996
- Amitriptyline effectively relieves neuropathic pain following treatment of breast cancerPain, 1996
- Psychopathology of Pancreatic CancerPsychosomatics, 1993
- Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnairesBritish Journal of Cancer, 1991
- Efficacy and safety of mianserin in the treatment of depression of women with cancerActa Psychiatrica Scandinavica, 1985